Stock Events

Stock Events

Search...

Regeneron Pharmaceuticals (REGN) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

9.55

10.32

11.09

11.86

Details

Expected EPS

10.617683

Actual EPS

11.56

Surprise EPS

0.94

Surprise Percent

+8.87%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 11.56 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.